PR & News

Recent Press Releases & News Mentions

March 9, 2023

Congressional Psychedelics Caucus

Michael Bogenschutz

January 10, 2023

Psilocybin for Alcohol Dependence Trial by B.More Principal Investigator

Michael Bogenschutz

January 1, 2023

Most Talked About JAMA Psychiatry Articles 2022

JAMA Network

November 6, 2022

Why aren’t there more ways
to treat alcoholism?

Washington Post, Katherine Ellison

October 27, 2022

Carey Turnbull Wears Many Hats as a Donor and Investor

Lucid News, Marc Gunther

October 14, 2022

B.More Psilocybin for AUD Program Principal Investigator, Dr. Michael Bogenschutz, to Present at Horizons New York Psychedelic Research Forum

Discounted tickets to attend in-person may be purchased using the code: BMORE-HNY-15

BMORE ANNOUNCEMENT

October 11, 2022

Magic mushrooms: An unlikely possible treatment for the rise in problem drinking

The San Antonio Report, Melissa Fletcher Stoeltje

September 28, 2022

Free Tickets for Psychedelic Capital Presentation by Dr. Michael Bogenschutz and Dr. Judy Ashworth

BMORE ANNOUNCEMENT

September 20, 2022

B.More to Present at Psychedelic Capital

BMORE ANNOUNCEMENT

August 26, 2022

B.More Receives FDA Approval for Psilocybin Phase 2b Trial

Microdose NewsDesk

August 25, 2022

B.More Receives FDA Investigational New Drug Approval for Psilocybin Alcohol Use Disorder Program Phase 2b Clinical Trial

BMORE PRESS RELEASE

August 24, 2022

B.More Principal Investigator, Michael Bogenschutz, Publishes Ground-breaking Trial on the Benefits of Psilocybin Therapy for Alcohol Dependence

BMORE PRESS RELEASE

August 24, 2022

Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder. A Randomized Clinical Trial

JAMA Psychiatry. Michael P. Bogenschutz, MD1; Stephen Ross, MD1; Snehal Bhatt, MD2; et al

ADDITIONAL B.MORE PHASE 2A TRIAL PEER REVIEW PUBLISHED COVERAGE

August 25, 2022

Psilocybin Therapy Sharply Reduces Excessive Drinking, Small Study Shows

New York Times. Andrew Jacobs

August 24, 2022

NYU research finds benefit for patients using ‘magic mushrooms’

ABC7 NY Eyewitness News

August 24, 2022

‘Magic mushroom’ psychedelic may help heavy drinkers quit

Associated Press. Carla K. Johnson

August 24, 2022

Psychedelics with psychotherapy helped heavy drinkers cut back, study finds

AXIOS. Tina Reed

August 24, 2022

Can Magic Mushrooms Help Alcoholics? NYU Study Shows Promise

Bloomberg. Tiffany Karey

August 24, 2022

Psilocybin ‘trips’ combined with therapy reduce alcohol use, study finds

CNN. Sandee LaMotte

August 24, 2022

New Study Shows Psilocybin Reduces Drinking in 83% of Patients

Microdose. Jason Najum

August 24, 2022

Psychedelic drug helped people with alcohol use disorder reduce drinking, study shows

NBC Nightly News. Kaitlin Sullivan, Akshay Syal, M.D., Kori Lynch and Harry Smith

August 24, 2022

Psilocybin alcoholism trial highlights problem for psychedelic science

News Atlas. Rich Haridy

August 24, 2022

Hilft Psilocybin gegen Alkoholsucht?

Spiegel Gesundheit. Nina Weber

August 24, 2022

Psilocybin shows promise for treating alcohol addiction, new study finds

STAT. Olivia Goldhill

August 24, 2022

Magic mushrooms’ psilocybin may help heavy drinkers cut back

The Guardian

August 24, 2022

Psilocybin-assisted therapy proves effective for alcohol use disorder: study

The Hill. Gianna Melillo

August 24, 2022

Psilocybin May Help Treat Alcohol Addiction, Study Shows

Time. Tara Law

August 24, 2022

Can psilocybin combat mental health issues? How magic mushrooms show promise in fighting addiction.

USA Today. Karen Weintraub

August 24, 2022

Psilocybin, Psychedelic Compound in Magic Mushrooms, Shown Effective for Alcohol Addiction

Wall Street Journal. Daniela Hernandez

Older News and PR Articles

August 11, 2022

Young Psychedelic Philanthropist Blazes Path for the Psychedelic Future

LUCID NEWS. Marc Gunther

July 25, 2022

B.More Submits FDA Investigational New Drug Application for Psilocybin Alcohol Use Disorder Program

BMORE PRESS RELEASE

July 25, 2022

Spotlight Interview | Carey Turnbull, Co-founder and CEO of B.More

Psychedelic Finance

June 1, 2022

The 18 clinical trials that could make or break the future of the $100 billion psychedelics industry

Business Insider, Dr. Catherine Schuster-Bruce, Yeji Jesse Lee, Shayanne Gal, Annie Fu, and Alex Ford

April 8, 2022

Funders at Johns Hopkins Shape The Future of Psychedelic Research

Lucid News, Marc Gunther

March 31, 2022

The Next Big Addiction Treatment

New York Times, Brendan Borrell

May 17, 2022

Journey Colab Looks to Mescaline for Treating Alcohol Use Disorder

Lucid News, Marc Gunther

March 10, 2022

Johns Hopkins, Yale, and NYU are teaming up to tackle a key bottleneck that will arise as psychedelics come to market

Business Insider, Yeji Jesse Lee

March 10, 2022

Grant Supports Development of Training for Psychiatrists in Psychedelic Medicine

Yale Medicine, Christopher Gardner

February 20, 2022

Psychoactive ingredient in ‘magic’ mushrooms may treat depression for much longer than traditional antidepressants when combined with therapy

Business Insider,  Dr. Catherine Schuster-Bruce 

July 9, 2021

How Should We Do Drugs Now?

The New York Times. Michael Pollan

April 6, 2021

Is it Possible to Create an Ethical Psychedelics Company?

VICE NEWS. Shayla Love

March 22, 2021

NYU Raises $10M For Psychedelic Research and Training Center

LUCID NEWS. Colin Newton

March 12, 2021

Wealthy donors are fueling a psychedelics renaissance as universities vie for funding to study ‘magic mushrooms’ and MDMA

BUSINESS INSIDER. Yeji Jesse Lee

February 25, 2021

NYU Establishes Center For Psychedelic Medicine With $10 Million From MindMed, Philanthropists

Forbes. Amanda Siebert

February 24, 2021

NYU Langone Health Establishes Center for Psychedelic Medicine

NYU Langone Health

February 17, 2020

Business gets ready to trip: How psychedelic drugs may revolutionize mental health care

FORTUNE. Jeffrey M. O’Brien

April 13, 2019

A Psychedelic Renaissance

The Chronicle of Philanthropy. Marc Gunther

May 15, 2018

How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence

Michael Pollan

October 31, 2015

The Trip Treatment: Research into psychedelics, shut down for decades, is now yielding exciting results

The New Yorker. Michael Pollan

January, 2015

Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study

The Chronicle of Journal of Psychopharmacology 29(3). Michael P Bogenschutz, Alyssa A Forcehimes, Jessica A Pommy, Claire E Wilcox, PCR Barbosa and Rick J Strassman

2015

Can psychedelic compounds play a part in drug dependence therapy?

The British journal of psychiatry. B. Sessa, M. Johnson

September 11, 2014

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction

Journal of Psychopharmacology. Matthew W Johnson, Albert Garcia-Romeu, Mary P Cosimano, Roland R Griffiths

Stay informed of B. More news and research:

GET INVOLVED